Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 31, 2019 - Issue 10
789
Views
26
CrossRef citations to date
0
Altmetric
Articles

Exploring new and existing PrEP modalities among female sex workers and women who inject drugs in a U.S. city

, , , , , , , , & show all
Pages 1207-1213 | Received 04 May 2018, Accepted 07 Feb 2019, Published online: 01 Mar 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Maria A. Corcorran, John D. Scott, Joe Tinsley, Anna Wald & Sara N. Glick. (2022) Awareness and Correlates of HIV Pre-Exposure Prophylaxis (PrEP) Among HIV-negative People Who Access Syringe Services in Seattle, Washington. Substance Use & Misuse 57:3, pages 337-343.
Read now

Articles from other publishers (25)

Stephen D. Ramos, Honor Woodward, Lynn Kannout & Steff Du Bois. (2023) Dimensional Reduction in Barriers and Facilitators to Pre-exposure Prophylaxis (PrEP) Uptake Willingness for Full-Service Sex Workers. Archives of Sexual Behavior.
Crossref
Yanhan Shen, Julie Franks, William Reidy, Halli Olsen, Chunhui Wang, Nadine Mushimbele, Richted Tenda Mazala, Tania Tchissambou, Faustin Malele, Apolinaire Kilundu, Trista Bingham, Gaston Djomand, Elie Mukinda, Raimi Ewetola, Elaine J. Abrams & Chloe A. Teasdale. (2023) Pre-exposure prophylaxis uptake concerns in the Democratic Republic of the Congo: Key population and healthcare workers perspectives. PLOS ONE 18:11, pages e0280977.
Crossref
Lauren Fynn, Katherine Gill, Melissa Wallace, Millicent Atujuna, Menna Duyver, Penelope Ngcobo, Hans Spiegel, Alex Rinehart, Sybil Hosek & Linda-Gail Bekker. (2023) “It’s already in your body and it’s preventing”: a qualitative study of African female adolescent’s acceptability and preferences for proxy HIV prevention methods in Cape Town, South Africa. BMC Public Health 23:1.
Crossref
Caroline K. Darlington, Rachele K. Lipsky, Anne M. Teitelman, Beryl A. Koblin, Annet Davis, Melonie Walcott, Peggy A. Compton & Hong-Van Tieu. (2023) HIV risk perception, pre-exposure prophylaxis (PrEP) awareness, and PrEP initiation intention among women who use drugs. Journal of Substance Use and Addiction Treatment 152, pages 209119.
Crossref
Lara Lorenzetti, Nhi Dinh, Ariane van der Straten, Virginia Fonner, Kathleen Ridgeway, Michelle Rodolph, Robin Schaefer, Heather‐Marie A. Schmidt & Rachel Baggaley. (2023) Systematic review of the values and preferences regarding the use of injectable pre‐exposure prophylaxis to prevent HIV acquisition. Journal of the International AIDS Society 26:S2.
Crossref
Daniel Grace, Mark GasparAlex WellsJad Sinno, Emerich DaroyaMichael MontessMark HullNathan J. LachowskyDarrell H.S. Tan. (2023) Injectable Pre-Exposure Prophylaxis for HIV Prevention: Perspectives on the Benefits and Barriers from Gay, Bisexual, and Queer Men and Health System Stakeholders in Ontario, Canada. AIDS Patient Care and STDs 37:6, pages 306-315.
Crossref
Ainoa Ugarte, Lorena de la Mora, David García, María Martínez-Rebollar, Elisa de Lazzari, Berta Torres, Alexy Inciarte, Juan Ambrosioni, Iván Chivite, Estela Solbes, Nicolás de Loredo, Guillermo Federico Del Carlo, Ana González-Cordón, José Luis Blanco, Esteban Martínez, Josep Mallolas & Montserrat Laguno. (2022) Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years’ Experience. Infectious Diseases and Therapy 12:2, pages 425-442.
Crossref
Kathrine Meyers, Nadia Nguyen, Jason E. Zucker, Bryan A. Kutner, Caroline Carnevale, Delivette Castor, Magdalena E. Sobieszczyk, Michael T. Yin, Sarit A. Golub & Robert H. Remien. (2022) The Long-Acting Cabotegravir Tail as an Implementation Challenge: Planning for Safe Discontinuation. AIDS and Behavior 27:1, pages 4-9.
Crossref
Christine Tagliaferri RaelRebecca GiguereSara SuttonElizabeth HornRobert J. SchiefferGeorge J. GreeneRichard D'AquilaEwa Bryndza TfailyPatrick F. KiserThomas J. Hope. (2022) Preferences Among Physicians and Men Who Have Sex with Men (MSM) for a Long-Acting, Removable Implant for HIV Prevention: A Discrete Choice Study. AIDS Research and Human Retroviruses 38:12, pages 898-908.
Crossref
Sarah Demart. (2022) « On n’arrive pas à les toucher » : la PrEP, les migrant.e.s africain.e.s et la production de l’ignorance. Global Health Promotion 29:3, pages 151-154.
Crossref
S Wilson Beckham, Andrea Mantsios, Noya Galai, Samuel Likindikoki, Jessie Mbwambo, Wendy Davis & Deanna Kerrigan. (2022) Acceptability of multiple modalities of pre-exposure prophylaxis (PrEP) among female sex workers in Tanzania: a mixed-methods study. BMJ Open 12:8, pages e058611.
Crossref
Joseph G. Rosen, Ju Nyeong Park, Kristin E. Schneider, Rebecca Hamilton White, S. Wilson Beckham, Jennifer L. Glick, Katherine H. A. Footer & Susan G. Sherman. (2022) Mapping Interests in Event-Driven and Long-Acting Pre-exposure Prophylaxis Formulations onto the HIV Risk Environment of Street-Based Female Sex Workers: A Latent Class Analysis. AIDS and Behavior 26:6, pages 1992-2002.
Crossref
Maryam Hassani & Sean D. Young. (2022) Potential Role of Conversational Agents in Encouraging PrEP Uptake. The Journal of Behavioral Health Services & Research.
Crossref
Robert J. SchiefferEwa Bryndza TfailyRichard D'AquilaGeorge J. GreeneAlex Carballo-DiéguezRebecca GiguereChristine Tagliaferri RaelPatrick F. KiserThomas J. Hope. (2022) Conjoint Analysis of User Acceptability of Sustained Long-Acting Pre-Exposure Prophylaxis for HIV. AIDS Research and Human Retroviruses 38:4, pages 336-345.
Crossref
Morgan M. Philbin, Sadie Bergen, Carrigan Parish, Deanna Kerrigan, Elizabeth N. Kinnard, Sarah Reed, Mardge H. Cohen, Oluwakemi Sosanya, Anandi N. Sheth, Adaora A. Adimora, Jennifer Cocohoba, Lakshmi Goparaju, Elizabeth T. Golub, Michael Vaughn, José I. GutierrezJr.Jr., Margaret A. Fischl, Maria Alcaide & Lisa R. Metsch. (2021) Long-Acting Injectable ART and PrEP Among Women in Six Cities Across the United States: A Qualitative Analysis of Who Would Benefit the Most. AIDS and Behavior 26:4, pages 1260-1269.
Crossref
Christopher Brokus, Sarah Kattakuzhy, Britt Gayle, Shivakumar Narayanan, Ashley Davis, Amelia Cover, Rahwa Eyasu, Emade Ebah, Onyinyechi Ogbumbadiugha-Weekes, Jennifer Hoffmann, Rachel Silk, Jasmine Stevens, Julia Mount, Catherine Gannon, Laura Nussdorf, Poonam Mathur, Phyllis Bijole, Miriam Jones, Randy Kier, David Sternberg, Aaron Greenblatt, Eric Weintraub, Henry Masur, Shyamasundaran Kottilil & Elana Rosenthal. (2022) Suboptimal Uptake, Retention, and Adherence of Daily Oral Prexposure Prophylaxis Among People With Opioid Use Disorder Receiving Hepatitis C Virus Treatment. Open Forum Infectious Diseases 9:3.
Crossref
Naomi F. Fields, Sarah Wood, Christina Amutah, C. Alix Timko, Danielle Petsis & Aletha Y. Akers. (2021) Identifying Opportunities to Discuss Pre-Exposure Prophylaxis During Contraceptive Coaching Discussions With Urban Adolescent Women. Journal of Adolescent Health 69:5, pages 824-830.
Crossref
Jaih B. Craddock, Laurenia C. MangumGloria Aidoo-FrimpongDarren L. Whitfield. (2021) The Associations of HIV Pre-Exposure Prophylaxis Interest and Sexual Risk Behaviors Among Young Black Women. AIDS Patient Care and STDs 35:7, pages 263-270.
Crossref
Colleen B. Mistler, Michael M. Copenhaver & Roman Shrestha. (2020) The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review. AIDS and Behavior 25:5, pages 1490-1506.
Crossref
Sarahmona M. Przybyla, Catherine Cerulli, Jacob Bleasdale, Kennethea Wilson, Melissa Hordes, Nabila El-Bassel & Diane S. Morse. (2020) “I think everybody should take it if they’re doing drugs, doing heroin, or having sex for money”: a qualitative study exploring perceptions of pre-exposure prophylaxis among female participants in an opioid intervention court program. Substance Abuse Treatment, Prevention, and Policy 15:1.
Crossref
Roman Shrestha, Elizabeth E. DiDomizio, Rayne S. Kim, Frederick L. Altice, Jeffrey A. Wickersham & Michael M. Copenhaver. (2020) Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs. Journal of Substance Abuse Treatment 117, pages 108058.
Crossref
Sarah K. CalabreseRachel W. GalvaoJohn F. DovidioTiara C. WillieCara B. SafonClair KaplanAbigail CaldwellOni BlackstockNicole J. PhillipsTrace S. Kershaw. (2020) Contraception as a Potential Gateway to Pre-Exposure Prophylaxis: US Women's Pre-Exposure Prophylaxis Modality Preferences Align with Their Birth Control Practices. AIDS Patient Care and STDs 34:3, pages 132-146.
Crossref
Milana Bogorodskaya, Steven A. Lewis, Douglas S. Krakower & Ann Avery. (2020) Low Awareness of and Access to Pre-exposure Prophylaxis But High Interest Among Heterosexual Women in Cleveland, Ohio. Sexually Transmitted Diseases 47:2, pages 96-99.
Crossref
Chen ZhangJames McMahonKevin FiscellaSarahmona PrzybylaAmy BraksmajerNatalie LeBlancYu Liu. (2019) HIV Pre-Exposure Prophylaxis Implementation Cascade Among Health Care Professionals in the United States: Implications from a Systematic Review and Meta-Analysis. AIDS Patient Care and STDs 33:12, pages 507-527.
Crossref
Chen Zhang, James McMahon, Janie Simmons, L. Lauren Brown, Robertson Nash & Yu Liu. (2019) Suboptimal HIV Pre-exposure Prophylaxis Awareness and Willingness to Use Among Women Who Use Drugs in the United States: A Systematic Review and Meta-analysis. AIDS and Behavior 23:10, pages 2641-2653.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.